Michael Johannes Pfluger, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Pancreatic Ductal | 5 | 2024 | 1727 | 1.320 |
Why?
|
| Pancreatic Neoplasms | 5 | 2024 | 5367 | 0.840 |
Why?
|
| Pancreatic Cyst | 1 | 2023 | 367 | 0.650 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 530 | 0.650 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 821 | 0.550 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2020 | 517 | 0.540 |
Why?
|
| Carcinoma, Papillary | 1 | 2020 | 785 | 0.500 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2020 | 1413 | 0.340 |
Why?
|
| Pancreatectomy | 2 | 2024 | 811 | 0.300 |
Why?
|
| Failed Back Surgery Syndrome | 1 | 2023 | 20 | 0.220 |
Why?
|
| Cyst Fluid | 1 | 2023 | 83 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 17878 | 0.200 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2023 | 335 | 0.200 |
Why?
|
| Spinal Stenosis | 1 | 2023 | 261 | 0.180 |
Why?
|
| Analgesia, Epidural | 1 | 2023 | 332 | 0.170 |
Why?
|
| Smad4 Protein | 1 | 2020 | 191 | 0.160 |
Why?
|
| Postoperative Care | 1 | 2024 | 1467 | 0.150 |
Why?
|
| Precancerous Conditions | 1 | 2024 | 980 | 0.140 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1852 | 0.130 |
Why?
|
| Morbidity | 1 | 2020 | 1750 | 0.120 |
Why?
|
| Organoids | 1 | 2020 | 744 | 0.110 |
Why?
|
| Carcinoma | 1 | 2024 | 2327 | 0.100 |
Why?
|
| Reoperation | 1 | 2020 | 4300 | 0.090 |
Why?
|
| DNA | 1 | 2023 | 7196 | 0.080 |
Why?
|
| Length of Stay | 1 | 2020 | 6418 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 9277 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 80566 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8542 | 0.060 |
Why?
|
| Humans | 9 | 2024 | 760617 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16967 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 6340 | 0.050 |
Why?
|
| Pancreatic Ducts | 1 | 2024 | 329 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39063 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15612 | 0.040 |
Why?
|
| United States | 1 | 2024 | 72272 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2023 | 1874 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2024 | 6807 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 3605 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 74115 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6126 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3593 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5200 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12719 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10432 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16571 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 169042 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29600 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2020 | 23416 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 64568 | 0.010 |
Why?
|
| Male | 2 | 2024 | 360358 | 0.010 |
Why?
|
| Female | 2 | 2024 | 392148 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 81368 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 220584 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 168201 | 0.000 |
Why?
|